| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/08/2009 | EP2076126A1 Novel combinations of dnak inhibitors with known antibacterial agents |
| 07/08/2009 | EP1981530B1 Composition containing several botulic toxins |
| 07/08/2009 | EP1781310A4 Articles of peptide nanostructures and method of forming the same |
| 07/08/2009 | EP1778268A4 Treatment of renal dysfunction and multiple myeloma using pacap compounds |
| 07/08/2009 | EP1750743A4 Oral formulations comprising bone morphogenetic proteins for treating metabolic bone diseases |
| 07/08/2009 | EP1740202A4 Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis |
| 07/08/2009 | EP1732588B1 Modulation of nkg2d |
| 07/08/2009 | EP1682074A4 Compositions and methods for healthy pregnancy |
| 07/08/2009 | EP1670413A4 Method of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i) |
| 07/08/2009 | EP1558287A4 Uses of human zven antagonists |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1536808B1 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 07/08/2009 | EP1511508A4 Method of treating dyslipidemic disorders |
| 07/08/2009 | EP1434596B1 Enhancement of immune responses by agonist 4-1bb-antibodies |
| 07/08/2009 | EP1401808B1 Gpe analogs and peptidomimetics |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1371730B1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/08/2009 | EP1360281B1 Regulation of human wee1-like serine/threonine protein kinase |
| 07/08/2009 | EP1301592B1 Recombinant bacterial phytases and uses thereof |
| 07/08/2009 | EP1232175B1 Method of forming a peptide-receptor complex with zsig33 polypeptides. |
| 07/08/2009 | EP1098658B1 Engineered proteins for analyte sensing |
| 07/08/2009 | EP0669988B2 Angiogenesis inhibitory antibodies |
| 07/08/2009 | CN101478983A Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof |
| 07/08/2009 | CN101478982A Method and composition for protection against radiation |
| 07/08/2009 | CN101474399A Insulin powder spray for lung inhalation and preparation method thereof |
| 07/08/2009 | CN101474398A Use of inhibitors for the treatment of disorders related to RTK hyperfunction |
| 07/08/2009 | CN101474397A Injection for treating hyperthyroidism |
| 07/08/2009 | CN100510073C Tryptase inhibitor |
| 07/08/2009 | CN100510068C A soluble complex comprising a retroviral surface glycoprotein |
| 07/08/2009 | CN100509846C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
| 07/08/2009 | CN100509842C Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 07/08/2009 | CN100509836C Clone, expression and biological activity of stingray tumor suppressor gene |
| 07/08/2009 | CN100509784C Inhibitors of hepatitis C virus ns3/ns4a serine protease |
| 07/08/2009 | CN100509061C 改进的螯合剂缀合物 Improved chelator conjugate |
| 07/08/2009 | CN100509058C Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 07/08/2009 | CN100509057C Antigen arrays for treatment of bone disease |
| 07/08/2009 | CN100509056C Vaccines including as an adjuvant type 1 IFN and process related thereto |
| 07/08/2009 | CN100509055C Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 07/08/2009 | CN100509054C Topical drug delivery using phosphatidylcholine |
| 07/08/2009 | CN100509053C Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 07/08/2009 | CN100508990C Acrochordon alleviation |
| 07/08/2009 | CN100508961C Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy, and the pharmaceutical use thereof |
| 07/08/2009 | CN100508953C Superloaded liposomes for drug delivery |
| 07/08/2009 | CA2645701A1 Process for obtaining a concentrate of von willebrand factor or a complex of factor viii/von willebrand factor and use of the same |
| 07/07/2009 | USRE40831 Passive immunotherapy; hybridoma cell line and antibodies produced by the cell lines; prevention and treatment of HBV infection |
| 07/07/2009 | US7557196 Expression vector comprising nucleotide sequences granulocyte colony stimulating factor for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/07/2009 | US7557195 granulocyte colony stimulating factor; provide a homogeneous product and a further purification process using the preparative column is not necessary; 1:1 molar ratio conjugates provide more improved stability and biological activity compared to G-CSF conjugates with several PEGs attached |
| 07/07/2009 | US7557194 Antibody materials for an IBD-associated polypeptide |
| 07/07/2009 | US7557193 Monoclonal antibody with binding specificity for lycosylated bile salt dependent lipase (BSDL) or fetoacinar pancreatic protein (FAPP) recognized by induced antibodies in a patient suffering from type I diabetes and purified from biological fluids of human or animal origin; hybridoma |
| 07/07/2009 | US7557192 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 07/07/2009 | US7557188 von Willebrand factor; von Willebrand's disease, phenotypic hemophilia, hemophilia A and factor VIII inhibitors |
| 07/07/2009 | US7557187 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins |
| 07/07/2009 | US7557185 Moraxella catarrhalis proteins |
| 07/07/2009 | US7557183 Polyethylene glycol linked GLP-1 compounds |
| 07/07/2009 | US7557182 Drug delivery across the blood-brain barrier using polypeptides; neurological diseases; aprotinin |
| 07/07/2009 | US7557137 Gamma-lactams as beta-secretase inhibitors |
| 07/07/2009 | US7557088 Methods and compositions for treating conditions |
| 07/07/2009 | US7557087 Treating or preventing vascular condition in patient by administering locally a therapeutically effective amount of a composition that increases metabolic production of nitric oxide by nitric oxide synthases; treatment of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease |
| 07/07/2009 | US7557086 for treating inflammation caused by Streptococcus by inhibiting Toll Like Receptor-induced cytokine secretion |
| 07/07/2009 | US7557084 IL-18 specific polypeptides and therapeutic uses thereof |
| 07/07/2009 | US7557083 Gastrokines and derived peptides including inhibitors |
| 07/07/2009 | US7557082 Treatment with cyclosporin A |
| 07/07/2009 | US7557081 Alpha-1-acid glycoprotein for the treatment of diabetes |
| 07/07/2009 | US7557080 Bacillus Cry9 family members |
| 07/07/2009 | US7557079 Metalloprotease proteins |
| 07/07/2009 | US7557078 Morphogen-induced nerve regeneration and repair |
| 07/07/2009 | US7556965 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 07/07/2009 | US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy |
| 07/07/2009 | US7556955 Nucleic acids encoding Candida kefyr cytosine deaminase |
| 07/07/2009 | US7556942 Genes in cancer and polynucleotides with codes for polypeptides with amino acid sequences |
| 07/07/2009 | US7556941 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders; used to stimulate the production of bone and/or connective tissue in both humans and non-human animals |
| 07/07/2009 | US7556926 Drug screening; diabetes, obesity, hyperlipemia, arteriosclerosis, hypertension, cardiovascular disorders |
| 07/07/2009 | US7556827 Implantable active ingredient depot comprising matrix of glyceryl-monooleate and at least one modifier molecule comprising 1,2-distearoyl-glycerophosphatidyl-ethanolamin-methyl-polyethylene glycol wherein matrix provides controlled release of active ingredient |
| 07/07/2009 | US7556824 Transdermal patch comprising hydralazine derivative antioxidant and isosorbide di- and/or mononitrate |
| 07/07/2009 | US7556821 Delivery system having a microprojection member that includes a plurality of microprojections adapted to pierce through stratum corneum into underlying epidermis layer; improved pharmacokinetics can comprise increased bioavailability of the PTH-based agent; treatment of osteoporosis and bone fractures |
| 07/07/2009 | US7556813 Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides |
| 07/07/2009 | US7556812 Purified polypeptide used for eliciting immune response against a West Nile virus associated disease |
| 07/07/2009 | US7556811 Peptide epitopes of apolipoprotein B |
| 07/07/2009 | US7556809 Utilizing vascular epithelial growth factor (VEGFR1) polypeptides, fragments and/or encoding oligonucleotides |
| 07/07/2009 | US7556808 Peptide used to inhibit the binding of HIV to cell surface receptor CD4 |
| 07/07/2009 | US7556807 Streptococcus mutans competence stimulating peptide (CSP) which inhibits biofilm formation; dental carries, periodontal disease, gingivitis, and endocarditis; inhibiting dental plaque formation |
| 07/07/2009 | US7556806 High mannose oligosaccharide cluster used to induce an immune response for increasing production of 2G12 antibodies |
| 07/07/2009 | US7556802 Pelleted feedstuff; pelleting stability, effective protection against enzyme exposure, improved storage stability of the feed additives and in particular the stability in mineral feed and mineral premix |
| 07/07/2009 | US7556798 Single, breath-activated step of delivering a drug to the pulmonary system by inhaling dry powder particles as carriers for adhered, adsorbed or chemically-combined bioactive agents; 50% of stored particle mass delivered; 5 milligrams of drug delivered; antiagglomerants; asthma; cyctic fibrosis |
| 07/07/2009 | US7556649 Methods and compositions for treating intervertebral disc degeneration |
| 07/07/2009 | CA2450033C Viral polymerase inhibitors |
| 07/07/2009 | CA2406790C Sustained release formulations |
| 07/07/2009 | CA2406119C Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 07/07/2009 | CA2378834C Pyrazinones, compositions containing such compounds |
| 07/07/2009 | CA2368165C Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 07/07/2009 | CA2353909C Betacellulin muteins |
| 07/07/2009 | CA2345353C Null igf for the treatment of cancer |
| 07/07/2009 | CA2304255C Hepatitis b virus polypeptides |
| 07/07/2009 | CA2286098C Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 07/07/2009 | CA2201161C Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/07/2009 | CA2168029C Prosaposin and cytokine-derived peptides as therapeutic agents |
| 07/07/2009 | CA2167692C Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 07/03/2009 | CA2648406A1 Translocator component derivatives and uses thereof |
| 07/03/2009 | CA2618278A1 Ipac derivatives and uses thereof |